ATNM - Actinium Pharmaceuticals - Stock Forecast

Healthcare - Sector

Coverage Performance Price Targets & Ratings Chart

ATNM is currently covered by 1 analysts with an average potential upside of $42.98 (510.35%) from yesterday's end of day stock price of $4.58. Actinium Pharmaceuticals activity chart has currently 0 price targets and 9 ratings on display.

Stock Analyst Price Targets - Review

Highest price target for ATNM is $13, Lowest price target is $6, average price target is $9.5.

Most recent stock forecast was given by JOSEPH PANTGINIS from HCWAINWRIGHT on 07-Sep-2023. First documented stock forecast 04-Jun-2020.

Best performing analysts who are covering ATNM - Actinium Pharmaceuticals:

Joseph Pantginis

Currently, out of the existing stock ratings of ATNM - 6 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Joseph Pantginis (HCWAINWRIGHT)

Buy

$45.42 (991.70%)

2 months 27 days ago

0/6 (0%)

$42.98 (510.35%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is ATNM (Actinium Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ATNM (Actinium Pharmaceuticals) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on ATNM (Actinium Pharmaceuticals)?

Joseph Pantginis works at HC WAINWRIGHT and has 0 price targets and 1 ratings on ATNM

Which analyst is the currently most bullish on ATNM (Actinium Pharmaceuticals)?

Joseph Pantginis with highest potential upside - $45.42